ARRY
Array Biopharma Inc
ARRY
ARRY
Delisted
ARRY was delisted on the 29th of July, 2019.
208 hedge funds and large institutions have $3.11B invested in Array Biopharma Inc in 2018 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 76 increasing their positions, 71 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding in top 10
Funds holding in top 10: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less capital invested
Capital invested by funds: $ → $
7% less funds holding
Funds holding: 223 → 208 (-15)
37% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 35
Holders
208
Holding in Top 10
8
Calls
$22.2M
Puts
$13.7M
Top Buyers
| 1 | +$41.2M | |
| 2 | +$32.2M | |
| 3 | +$24.6M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$19M |
| 5 |
PCM
Peregrine Capital Management
Minneapolis,
Minnesota
|
+$17M |
Top Sellers
| 1 | -$13.4M | |
| 2 | -$10M | |
| 3 | -$9.07M | |
| 4 |
Wellington Management Group
Boston,
Massachusetts
|
-$8.61M |
| 5 |
6CM
683 Capital Management
New York
|
-$7.55M |